Open access
Oct 2026
BETA-BLOCKER THERAPY AFTER MYOCARDIAL INFARCTION IN PATIENTS WITHOUT HEART FAILURE: A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
Beta-blocker (BB) therapy after myocardial infarction (MI) in patients with reduced left ventricular ejection fraction (LVEF) is well established. However, recent randomised controlled trials (RCTs) in post-MI patients without significantly impaired LVEF have yielded conflicting results. This meta-analysis aimed...
I. F. Arba, A. Primiputri, M. B. A. Paramarta et al.
· European Heart Journal, Supp... · 0 citations